Near-Patient Molecular Solutions Market

Future Market Insights

Key Insight

The near-patient molecular solutions market is projected to grow from USD 4.1 billion in 2025 to USD 8.9 billion by 2035, at a CAGR of 8.0%. PCR-based will dominate with a 41.6% market share, while infectious diseases testing kits will lead the product type segment with a 48.3% share.

August 07, 2025

Anurag Sharma

309 Pages

Cite this Report

Near-Patient Molecular Solutions Market

https://www.futuremarketinsights.com/reports/near-patient-molecular-solutions-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Hoffmann-La Roche
Siemens

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Near-Patient Molecular Solutions Market

Key Players

Similar Industry Reports